Premium
Importance of tumor size as a prognostic factor after partial liver resection for solitary hepatocellular carcinoma: Implications on the current AJCC staging system
Author(s) -
Goh Brian K. P.,
Teo JinYao,
Chan ChungYip,
Lee SerYee,
Jeyaraj Premaraj,
Cheow PengChung,
Chow Pierce K. H.,
Ooi London L. P. J.,
Chung Alexander Y. F.
Publication year - 2016
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.24099
Subject(s) - medicine , hepatocellular carcinoma , cirrhosis , multivariate analysis , oncology , overall survival , carcinoma , gastroenterology
Background Presently, the impact of tumors size as a prognostic factor after curative liver resection (LR) for solitary hepatocellular carcinoma (HCC) remains controversial. This study was performed to determine the prognostic factors of patients undergoing LR for solitary HCC with special emphasis on the importance of tumor size. Methods Between 2000 and 2013, 560 patients underwent curative LR for solitary primary HCC which met the study criteria. Results One‐hundred and seventy‐eight patients underwent major hepatectomies and the overall in‐hospital mortality was 2.0%. There were 282 patients (50.4%) with liver cirrhosis. The 5‐year overall survival (OS) was 64% and recurrence free survival (RFS) was 50%, respectively. Multivariate analyses demonstrated that cirrhosis, microvascular invasion and size were independent predictors of RFS and cirrhosis, microvascular invasion and age were independent prognostic factors of OS. Subset analysis demonstrated that tumor size was a prognostic factor for solitary HCC with microvascular invasion (AJCC T2) but not solitary HCC without microvascular invasion (AJCC T1). Conclusions Size, microvascular invasion, and cirrhosis are independent prognostic factors of RFS for solitary HCC after LR. Tumor size is an important prognostic factor in T2 but not T1 solitary tumors. These findings suggest that the current AJCC TNM staging system may need to be revised. J. Surg. Oncol. 2016;113:89–93 . © 2015 Wiley Periodicals, Inc.